文献速递血液透析通路

Vascular Quality Initiative中上臂肱动脉-贵要静脉动静脉瘘一期与二期手术的比较

Comparison of one-stage and two-stage upper arm brachiobasilic arteriovenous fistula in the Vascular Quality Initiative.
PubMed 文献 · J Vasc Surg · 2018-10-06

基于Vascular Quality Initiative(2010-2016)2648例上臂肱动脉-贵要静脉动静脉瘘(BBAVF)患者,比较一期与二期手术结局。一期BBAVF 12个月初级通畅率较高(49.1% vs 40.4%;P=0.005),但次级通畅率相当(80.0% vs 77.9%;P=0.54);一期术后出血、伤口感染和手臂肿胀更高。多变量分析中12个月初级通畅丧失风险无显著差异(aHR 1.12;95%CI 0.97-1.30;P=0.12),二期BBAVF 3个月手臂肿胀风险显著更低(aHR 0.35;95%CI 0.16-0.77;P=0.009)。

要点

  • 一期BBAVF 12个月初级通畅率49.1% vs 二期40.4%(P=0.005),次级通畅率80.0% vs 77.9%(P=0.54)无显著差异。
  • 一期BBAVF术后出血4% vs 1.5%、伤口感染1.01% vs 0.4%、手臂肿胀2.1% vs 0.8%均更高。
  • 多变量分析中二期BBAVF 3个月手臂肿胀风险显著更低(aHR 0.35;95%CI 0.16-0.77;P=0.009)。

核心结论

  • 数据显示一期与二期BBAVF在12个月初级或次级通畅率方面无差异。

研究设计与样本

  • 回顾性队列研究,纳入Vascular Quality Initiative数据集(2010-2016)2648例接受BBAVF的患者,比较一期与二期技术。

主要发现

  • 一期BBAVF 1234例(47%),二期1414例(53%),其中1848例(70%)手术时正在透析,1795例(68%)有既往通路史。
  • 一期BBAVF患者更可能为男性(54% vs 45%;P<.001)、白人(60% vs 41%;P<.001)和有冠状动脉疾病史(22% vs 17%;P=.001)。
  • 一期BBAVF患者静脉直径更大(4.1 vs 3.4 mm;P<.001),住院手术比例更高(21% vs 13%;P<.001)。
  • 一期BBAVF 12个月初级通畅率更高(49.1% vs 40.4%;P=.005),次级通畅率相当(80.0% vs 77.9%;P=.54)。
  • 一期BBAVF术后出血(4% vs 1.5%;P<.001)、伤口感染(1.01% vs 0.4%;P=.047)和手臂肿胀(2.1% vs 0.8%;P=.006)更高。

关键数值与推荐

  • 多变量分析中,12个月初级通畅丧失(aHR 1.12;95%CI 0.97-1.30;P=.12)和3个月伤口感染(aHR 0.42;95%CI 0.14-1.25;P=.12)在两种方法间相似。
  • 二期BBAVF 3个月手臂肿胀风险显著更低(aHR 0.35;95%CI 0.16-0.77;P=.009)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: An upper arm brachiobasilic arteriovenous fistula (BBAVF) is a reliable autogenous hemodialysis access created with a one-stage or two-stage technique. Although both techniques are variably used, the optimal approach is uncertain. In this study, we compared the outcomes of one-stage and two-stage BBAVF procedures. METHODS: We identified 2648 patients who had received BBAVFs within the Vascular Quality Initiative data set (2010-2016) and compared those created using the one-stage and two-stage technique. The primary outcome measures were primary and secondary patency rates at 12 months. Other outcomes assessed were wound infection, steal, and swelling at 3 months. The log-rank test was used to evaluate patency by Kaplan-Meier analysis. Cox proportional hazards models were used to examine the adjusted association between surgical technique and outcomes. RESULTS: There were 1234 (47%) one-stage and 1414 (53%) two-stage BBAVFs in the study cohort, including 1848 (70%) patients who were on dialysis at the time of surgery and 1795 (68%) patients with a history of previous access. Patients who underwent a one-stage BBAVF were more likely to be male (54% vs 45%; P < .001), to be white (60% vs 41%; P < .001), and to have a history of coronary artery disease (22% vs 17%; P = .001). Patients undergoing one-stage BBAVFs have larger vein diameters (4.1 vs 3.4 mm; P < .001) and have the procedure in an inpatient setting (21% vs 13%; P < .001) compared with patients undergoing a two-stage procedure. The 12-month primary patency rate was higher for the one-stage BBAVF (49.1% vs 40.4%; P = .005), although the secondary patency rate was comparable (80.0% vs 77.9%; P = .54). Postoperative bleeding (4% vs 1.5%; P < .001), wound infection (1.01% vs 0.4%; P = .047), and arm swelling (2.1 % vs 0.8%; P = .006) were higher for one-stage BBAVFs. In multivariable analysis, although loss of primary patency at 12 months (adjusted hazard ratio [aHR], 1.12; 95% confidence interval [CI], 0.97-1.30; P = .12) and 3-month wound infection (aHR, 0.42; 95% CI, 0.14-1.25, P = .12) were similar between the two approaches, the risk of 3-month arm swelling was significantly lower for two-stage BBAVFs (aHR, 0.35; 95% CI, 0.16-0.77; P = .009). CONCLUSIONS: Whereas surgeons were more likely to perform a two-stage BBAVF in patients with a history of previously failed access and smaller basilic vein, our data show no difference in primary or secondary patency of one-stage and two-stage BBAVFs at 12 months.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Tan TW, Siracuse JJ, Brooke BS, et al. Comparison of one-stage and two-stage upper arm brachiobasilic arteriovenous fistula in the Vascular Quality Initiative. J Vasc Surg. 2018. PMID: 30301685. doi:10.1016/j.jvs.2018.07.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。